ATIQCTPC: a nanomedicine capable of targeting tumor and blocking thrombosis in vivo

To overcome the harmful side effects, low tolerance, and undesirable outcomes of the anticancer drugs, we used ethane-1,2-diamine to bridge antitumoral (S)-3-acetyl-4-oxo-tetrahydroindolo[2,3-a]quinolizine-6-carboxylic acid (ATIQC) and tumor-targeting d-glucuronic acid, thereby providing (6S)-3-acet...

Descripción completa

Detalles Bibliográficos
Autores principales: Xu, Xinyi, Wang, Yuji, Wu, Jianhui, Hu, Xi, Zhu, Haimei, Zhang, Xiaoyi, Wang, Yaonan, Gui, Lin, Zhao, Ming, Peng, Shiqi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2017
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5476604/
https://www.ncbi.nlm.nih.gov/pubmed/28652742
http://dx.doi.org/10.2147/IJN.S129989

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5476604/
https://www.ncbi.nlm.nih.gov/pubmed/28652742
http://dx.doi.org/10.2147/IJN.S129989

Ejemplares similares